We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).
- Authors
Laribi, Kamel; Poulain, Stéphanie; Willems, Lise; Merabet, Fatiha; Le Calloch, Ronan; Eveillard, Jean R.; Herbaux, Charles; Roos‐Weil, Damien; Chaoui, Driss; Roussel, Xavier; Tricot, Sabine; Dupuis, Jehan; Dartigeas, Caroline; Bareau, Benoit; Bene, Marie C.; Baugier de Materre, Alix; Leblond, Véronique
- Abstract
The article focuses on study that evaluated the efficacy and safety of bendamustine plus rituximab (BR) in symptomatic untreated patients with Waldenstr€om macroglobulinaemia (WM). It mentions the results like a patient developed myelodysplastic syndrome after BR initiation and other developed breast cancer.
- Publication
British Journal of Haematology, 2019, Vol 186, Issue 1, p146
- ISSN
0007-1048
- Publication type
Academic Journal
- DOI
10.1111/bjh.15718